News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
377,234 Results
Type
Article (14812)
Company Profile (115)
Press Release (362302)
Multimedia
Podcasts (53)
Webinars (9)
Section
Business (113042)
Career Advice (459)
Deals (18703)
Drug Delivery (41)
Drug Development (31412)
Employer Resources (52)
FDA (8855)
Job Trends (7734)
News (173518)
Policy (12443)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Standard (3)
Academia (1341)
Accelerated approval (10)
Allergies (71)
Alliances (34980)
ALS (42)
Alzheimer's disease (628)
Antibody-drug conjugate (ADC) (179)
Approvals (9061)
Artificial intelligence (444)
Autoimmune disease (61)
Automation (31)
Bankruptcy (131)
Best Places to Work (6556)
BIOSECURE Act (7)
Biosimilars (31)
Biotechnology (85)
Bladder cancer (62)
Brain cancer (27)
Breast cancer (262)
Cancer (2196)
Cardiovascular disease (149)
Career advice (418)
Career pathing (9)
CAR-T (200)
CDC (8)
Cell therapy (489)
Cervical cancer (21)
Clinical research (26009)
Collaboration (1232)
Compensation (231)
Complete response letters (8)
COVID-19 (1229)
CRISPR (85)
C-suite (483)
Cystic fibrosis (62)
Data (2659)
Decentralized trials (1)
Denatured (29)
Depression (43)
Diabetes (212)
Diagnostics (5146)
Digital health (36)
Diversity (7)
Diversity, equity & inclusion (9)
Drug discovery (165)
Drug pricing (19)
Drug shortages (4)
Duchenne muscular dystrophy (86)
Earnings (40607)
Editorial (9)
Employer branding (9)
Employer resources (46)
Events (53579)
Executive appointments (551)
FDA (10465)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (5)
Frontotemporal dementia (8)
Funding (897)
Gene editing (171)
Generative AI (38)
Gene therapy (345)
GLP-1 (308)
Government (1285)
Grass and pollen (3)
Guidances (220)
Healthcare (9969)
HIV (23)
Huntington's disease (13)
IgA nephropathy (26)
Immunology and inflammation (68)
Immuno-oncology (19)
Indications (50)
Infectious disease (1370)
Inflammatory bowel disease (81)
Inflation Reduction Act (5)
Influenza (73)
Intellectual property (151)
Interviews (52)
IPO (8088)
IRA (10)
Job creations (1442)
Job search strategy (365)
JPM (20)
Kidney cancer (6)
Labor market (24)
Layoffs (132)
Leadership (7)
Legal (2546)
Liver cancer (43)
Longevity (6)
Lung cancer (247)
Lymphoma (171)
Machine learning (34)
Management (18)
Manufacturing (524)
MASH (37)
Medical device (11847)
Medtech (11896)
Mergers & acquisitions (11249)
Metabolic disorders (403)
Multiple sclerosis (63)
NASH (3)
Neurodegenerative disease (120)
Neuropsychiatric disorders (19)
Neuroscience (1084)
NextGen: Class of 2026 (3545)
Non-profit (1545)
Now hiring (15)
Obesity (141)
Opinion (97)
Ovarian cancer (92)
Pain (105)
Pancreatic cancer (102)
Parkinson's disease (118)
Partnered (20)
Patents (301)
Patient recruitment (244)
Peanut (31)
People (33788)
Pharmaceutical (19)
Pharmacy benefit managers (3)
Phase 1 (9563)
Phase 2 (11681)
Phase 3 (7591)
Pipeline (2554)
Policy (59)
Postmarket research (512)
Preclinical (4295)
Press Release (66)
Prostate cancer (96)
Psychedelics (6)
Radiopharmaceuticals (177)
Rare diseases (302)
Real estate (3408)
Recruiting (23)
Regulatory (10408)
Reports (20)
Research institute (1309)
Resumes & cover letters (69)
Rett syndrome (21)
RNA editing (9)
RSV (40)
Schizophrenia (32)
Series A (162)
Series B (109)
Service/supplier (6)
Sickle cell disease (32)
Special edition (1)
Spinal muscular atrophy (60)
Sponsored (21)
Startups (2536)
State (2)
Stomach cancer (3)
Supply chain (48)
Tariffs (10)
The Weekly (23)
Vaccines (497)
Venture capital (43)
Weight loss (49)
Women's health (48)
Worklife (2)
Date
Today (4)
Last 7 days (274)
Last 30 days (1111)
Last 365 days (14716)
2026 (1399)
2025 (15072)
2024 (18765)
2023 (22141)
2022 (30868)
2021 (32582)
2020 (30612)
2019 (25894)
2018 (19543)
2017 (18914)
2016 (17804)
2015 (20600)
2014 (15192)
2013 (12762)
2012 (13813)
2011 (14096)
2010 (12841)
Location
Africa (325)
Alabama (69)
Alaska (6)
Arizona (178)
Arkansas (10)
Asia (24909)
Australia (4322)
California (5328)
Canada (1670)
China (548)
Colorado (284)
Connecticut (236)
Delaware (107)
Europe (51036)
Florida (906)
Georgia (220)
Hawaii (2)
Idaho (33)
Illinois (471)
India (33)
Indiana (263)
Iowa (8)
Japan (271)
Kansas (101)
Kentucky (15)
Louisiana (18)
Maine (22)
Maryland (718)
Massachusetts (3547)
Michigan (274)
Minnesota (407)
Mississippi (4)
Missouri (98)
Montana (27)
Nebraska (15)
Nevada (51)
New Hampshire (83)
New Jersey (1567)
New Mexico (18)
New York (1420)
North Carolina (758)
North Dakota (9)
Northern California (2278)
Ohio (169)
Oklahoma (16)
Oregon (24)
Pennsylvania (1015)
Puerto Rico (19)
Rhode Island (34)
South America (512)
South Carolina (60)
South Dakota (1)
Southern California (2267)
Tennessee (104)
Texas (882)
United States (19780)
Utah (193)
Vermont (1)
Virginia (90)
Washington D.C. (18)
Washington State (504)
West Virginia (3)
Wisconsin (87)
Wyoming (1)
377,234 Results for "mauna kea technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
Mauna Kea Technologies Unveils CellTolerance, a Subsidiary Dedicated to its Unique Program for the Detection and Treatment of Food Intolerances
Mauna Kea Technologies, inventor of Cellvizio®, the multidisciplinary platform for probe-based and needle-based confocal laser endomicroscopy, unveils its new subsidiary CellTolerance, fully dedicated to its unique program for the detection and treatment of food intolerances associated with Irritable Bowel Syndrome.
June 26, 2024
·
8 min read
Business
Telix and Mauna Kea Technologies to Expand Collaboration in Urologic Oncology Surgery
Telix Pharmaceuticals Limited and Paris-based Mauna Kea Technologies, announce an expansion of the IRiS Alliance[1] through a strategic €6.0 million investment to develop new hybrid pharmaceutical-device products through the combination of Telix’s cancer-targeting agents with Mauna Kea’s Cellvizio® surgical endomicroscopy platform.
November 13, 2023
·
8 min read
Business
Telix Pharmaceuticals Limited and Mauna Kea Technologies Announce the “Imaging and Robotics in Surgery (IRiS) Alliance”
Telix Pharmaceuticals Limited and Mauna Kea Technologies Announce the “Imaging and Robotics in Surgery (IRiS) Alliance” The IRiS Alliance is an exclusive scientific and clinical research collaboration that combines two highly complementary technologies to deliver greater precision in the diagnosis and surgical management of urological cancers.
December 15, 2020
·
6 min read
Policy
Mauna Kea Technologies Announces Two New Publications Demonstrating the Efficacy, Safety and Accuracy of Cellvizio® for Pancreatic Cyst Evaluation
Mauna Kea Technologies (Paris:MKEA) (OTCQX:MKEAY) (Euronext: MKEA) inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (pCLE/nCLE) platform, today announced the publication of a peer-reviewed meta-analysis and of an international Delphi consensus report based on a systematic, evidence-based review of endoscopic ultrasound (EUS) guided needle-based confocal laser endomicroscopy for pancreatic cystic lesion (PCL) evaluation. The
November 4, 2020
·
4 min read
Deals
Mauna Kea Technologies Announces Strategic Equity Investment of €7.5 Million by Johnson & Johnson Innovation
Mauna Kea Technologies inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy platform, today announced a strategic equity investment of 7.5 million euro by Johnson & Johnson Innovation – JJDC, Inc..
December 16, 2019
·
6 min read
FDA
Mauna Kea Technologies Receives FDA Clearance And CE Marking For Its Next-Generation Cellvizio® Platform
Mauna Kea Technologies (Paris:MKEA) (OTCQX:MKEAY) (Euronext: MKEA) inventor of Cellvizio®, the multidisciplinary probe- and needle-based confocal laser endomicroscopy (pCLE/nCLE) platform, today announced today that it has obtained 510(k) clearance ( K193416 ) from the U.S. Food and Drug Admin
March 3, 2020
·
4 min read
Policy
Mauna Kea Technologies: Cellvizio® Endorsed By the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) as a Safe and Effective Diagnostic Tool
Mauna Kea Technologies (Paris:MKEA) (OTCQX:MKEAY) (Euronext: MKEA) inventor of Cellvizio®, the multidisciplinary probe- and needle-based confocal laser endomicroscopy (pCLE/nCLE) platform, today announced that the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) Technology and Value Assessment Committee (TAVAC) published a review on the safety and efficacy of confocal laser endomicroscopy as a diagnostic tool for the evaluation of gastrointestinal pathologies.
May 26, 2020
·
5 min read
Genetown
Mauna Kea Technologies Announces Publication of Positive Results on Needle-Based Endomicroscopy for the Clinical Management of Pancreatic Cystic Lesions
Mauna Kea Technologies (Paris:MKEA) (OTCQX:MKEAY) inventor of Cellvizio®, the multidisciplinary probe- and needle-based confocal laser endomicroscopy (pCLE/nCLE) platform, today announced a publication that demonstrates how Cellvizio positively impacts the diagnostic yield and the clinical management of pancreatic cystic lesions (PCL)
January 8, 2020
·
5 min read
Business
Mauna Kea Technologies Provides an Update on Its Commercial Partnership Agreement for Urological Applications
Mauna Kea Technologies inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy platform, announced a mutual decision to terminate the development and distribution agreements with Cook Medical.
February 21, 2019
·
4 min read
Business
Mauna Kea Technologies Appoints Experienced Healthcare Executive, Molly O’Neill, to Board of Directors
Mauna Kea Technologies today announced the appointment of Molly O’Neill to the Company’s Board of Directors, effective immediately.
January 15, 2018
·
4 min read
1 of 37,724
Next